AveXis
Specializing in groundbreaking gene therapies for rare neurological genetic diseases, impacting lives profoundly.
est. 2013
Neurogene Inc.
Reimagining the future for rare neurological diseases
130 employees · est. 2018 · New York, United States
AveXis is the older company (2013 vs 2018).
Side-by-Side Comparison
| Metric | AveXis | Neurogene Inc. |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | New York, United States |
| Employees | ||
| Employees | Not tracked yet | 130 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Grant | Unknown |
| Total Funding | ||
| Total Funding | $75.10M | $478.50M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Services | ||
| Services | Not tracked yet | Gene therapy development, Proprietary transgene regulation technology, Clinical research and trials, Patient and family support, Manufacturing of genetic medicines |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare neurological diseases, Families of patients, Healthcare professionals, Biotechnology and pharmaceutical partners, Investors |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Neurological Genetic Diseases, Rare Diseases, Medical Innovation, Novartis, Acquisition, Life-Threatening Conditions, Research & Development, Therapeutic Innovations | Rare Neurological Diseases, Genetic Medicines, Genomics Revolution, Neurological Disorders, Therapeutics Development, Gene Therapy, Pediatric Neurology, Developmental Delay, Medical Innovation, Global Collaboration, Rare Disease Solutions, Precision Medicine, Patient-Centric Approach |
| Website | ||
| Website | avexis.com | neurogene.com |
About AveXis
AveXis is a biotechnology startup specializing in groundbreaking gene therapies for rare neurological genetic diseases, impacting lives profoundly. Founded in 2013, the company was later acquired by Novartis on May 14, 2018, and adopted the name Novartis Gene Therapies in 2020. AveXis focuses on dev...
About Neurogene Inc.
Neurogene Inc., founded in 2018, is making significant strides in the Biotechnology sector by developing genetic medicines aimed at treating rare neurological diseases. With the slogan "Reimagining the future for rare neurological diseases," the company is on a mission to address unmet medical needs...
We will tell you when either one moves
BounceWatch watches AveXis and Neurogene Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AveXis and Neurogene Inc. — by email.
Frequently Asked Questions
Compare AveXis with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at AveXis on 11 Sep 2024, and Neurogene Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.